Across TCGA pan-cancer cohorts, PPP4R3C Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PPP4R3C data layer compared with 16 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PPP4R3C Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PPP4R3C expression acts as an unfavorable survival marker.

LUAD and LUSC are the cancer types where PPP4R3C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.213	0.676	.012	6	view →
LUSC	OS	Median	All	0.192	0.724	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: PPP4R3C tumor-vs-normal RNA expression · all PPP4R3C data types